Search results
28 maj 2024 · Prevention and therapy of delirium are based on the following principles: Avoiding factors known to cause or aggravate delirium, such as multiple medications, dehydration, immobilization, sensory impairment, and disruption of the sleep-wake cycle. Identifying and treating the underlying acute illness.
2 wrz 2014 · Validated assessment tools exist for screening, diagnosing and monitoring the severity of delirium in cancer care. The level of investigative and therapeutic intervention in a delirium...
Both risk factors and precipitating causes of delirium have been identified in older patients with cancer. Risk factors include advanced age and cognitive impairment, while associated precipitants include hematological malignancies, medications, hypoxia, dehydration, and inflammation.
Delirium is the most common neuropsychiatric complication seen in patients with cancer, and it is associated with significant morbidity and mortality. Increased health care costs, prolonged hospital stays, and long-term cognitive decline are other well-recognized adverse outcomes of delirium.
Validated assessment tools exist for screening, diagnosing and monitoring the severity of delirium in cancer care. The level of investigative and therapeutic intervention in a delirium episode is determined by the patient's estimated prognosis and the agreed goals of care.
4 sty 2016 · The temporal onset of symptoms of delirium is acute (hours to days), not insidious (months to years) as in dementia. In elderly patients with cancer, delirium is often superimposed on dementia, giving rise to a particularly difficult diagnostic challenge.
6 paź 2009 · Summarize the current evidence regarding strategies for the assessment and management of delirium in advanced cancer. Outline the medications most commonly implicated for drug-induced delirium. Compare the various pharmacological agents available for use in managing cancer-related delirium.